Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double-Blind, Placebo-Controlled REGAIN, and Pooled EVOLVE-1 and EVOLVE-2 Studies Article (Web of Science) Early Access (Web of Science)

cited authors

  • Smitherman, Todd A.; Tietjen, Gretchen E.; Schuh, Kory; Skljarevski, Vladimir; Lipsius, Sarah; D'Souza, Deborah N.; Pearlman, Eric M.

publication date

  • October 16, 2020


published in



  • anxiety
  • comorbid
  • depression
  • galcanezumab
  • migraine
  • prevention